What's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
History of cancer immunotherapy
PEMBROSARC: pembrolizumab combinations for advanced sarcoma
A golden age for bladder cancer publications
Straightforward study design: SPARTAN trial of apalutamide for nmCRPC